TRANSTHERA SCIENCES (NANJING), INC. - B - H SHARES
(HKEX: 2617)
TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.
79.250 -
+1.350
(+1.73%)
Range
75.300 - 82.500
(9.56%)
Open
77.500
Previous Close
77.900
Bid Price
79.150
Bid Volume
('000)
0.5
Ask Price
79.300
Ask Volume
('000)
1.5
Volume
('000)
1,751.6
Value
137,749,698
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
